China Sanjiang Fine Chemicals Company Limited (2198.HK)
HKD 1.77
(-1.12%)
HKD 1.77
(-1.12%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 13.12 Billion CNY | 48.88% |
| 2022 | 8.81 Billion CNY | -7.17% |
| 2021 | 9.49 Billion CNY | 14.13% |
| 2020 | 8.32 Billion CNY | -9.45% |
| 2019 | 9.19 Billion CNY | -4.12% |
| 2018 | 9.58 Billion CNY | 7.74% |
| 2017 | 8.89 Billion CNY | 33.85% |
| 2016 | 6.64 Billion CNY | 33.84% |
| 2015 | 4.96 Billion CNY | 36.56% |
| 2014 | 3.63 Billion CNY | -7.71% |
| 2013 | 3.94 Billion CNY | 56.28% |
| 2012 | 2.52 Billion CNY | 21.33% |
| 2011 | 2.07 Billion CNY | 31.32% |
| 2010 | 1.58 Billion CNY | 23.1% |
| 2009 | 1.28 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 9.23 Billion CNY | 0.0% |
| 2023 Q2 | 4.59 Billion CNY | 0.0% |
| 2023 FY | 13.12 Billion CNY | 48.88% |
| 2023 Q4 | 8.53 Billion CNY | 0.0% |
| 2022 Q4 | 3.95 Billion CNY | 0.0% |
| 2022 FY | 8.81 Billion CNY | -7.17% |
| 2022 Q2 | 4.86 Billion CNY | 0.0% |
| 2021 FY | 9.49 Billion CNY | 14.13% |
| 2021 Q4 | 4.72 Billion CNY | 0.0% |
| 2021 Q2 | 4.77 Billion CNY | 0.0% |
| 2020 Q2 | 3.77 Billion CNY | 0.0% |
| 2020 Q4 | 4.54 Billion CNY | 0.0% |
| 2020 FY | 8.32 Billion CNY | -9.45% |
| 2019 Q4 | 5 Billion CNY | 0.0% |
| 2019 Q2 | 4.19 Billion CNY | 0.0% |
| 2019 FY | 9.19 Billion CNY | -4.12% |
| 2018 FY | 9.58 Billion CNY | 7.74% |
| 2018 Q2 | 4.74 Billion CNY | 0.0% |
| 2018 Q4 | 4.84 Billion CNY | 0.0% |
| 2017 FY | 8.89 Billion CNY | 33.85% |
| 2017 Q2 | 4.19 Billion CNY | 0.0% |
| 2017 Q4 | 4.7 Billion CNY | 0.0% |
| 2016 Q2 | 2.88 Billion CNY | 0.0% |
| 2016 FY | 6.64 Billion CNY | 33.84% |
| 2016 Q4 | 3.76 Billion CNY | 0.0% |
| 2015 Q4 | 3.06 Billion CNY | 0.0% |
| 2015 FY | 4.96 Billion CNY | 36.56% |
| 2015 Q2 | 1.89 Billion CNY | 0.0% |
| 2014 FY | 3.63 Billion CNY | -7.71% |
| 2014 Q4 | 1.83 Billion CNY | 0.0% |
| 2014 Q2 | 1.8 Billion CNY | 0.0% |
| 2013 Q4 | 1.95 Billion CNY | 0.0% |
| 2013 Q2 | 1.98 Billion CNY | 0.0% |
| 2013 FY | 3.94 Billion CNY | 56.28% |
| 2012 Q1 | 630.36 Million CNY | 0.0% |
| 2012 Q3 | 630.36 Million CNY | 0.0% |
| 2012 Q2 | 630.36 Million CNY | 0.0% |
| 2012 Q4 | 985.11 Million CNY | 56.28% |
| 2012 FY | 2.52 Billion CNY | 21.33% |
| 2011 Q4 | 630.36 Million CNY | 21.33% |
| 2011 Q2 | 519.54 Million CNY | 0.0% |
| 2011 FY | 2.07 Billion CNY | 31.32% |
| 2011 Q3 | 519.54 Million CNY | 0.0% |
| 2011 Q1 | 519.54 Million CNY | 0.0% |
| 2010 FY | 1.58 Billion CNY | 23.1% |
| 2010 Q3 | 395.63 Million CNY | 0.0% |
| 2010 Q4 | 519.54 Million CNY | 31.32% |
| 2010 Q1 | 395.63 Million CNY | 0.0% |
| 2010 Q2 | 395.63 Million CNY | 0.0% |
| 2009 Q2 | 321.38 Million CNY | 0.0% |
| 2009 FY | 1.28 Billion CNY | 0.0% |
| 2009 Q3 | 321.38 Million CNY | 0.0% |
| 2009 Q4 | 395.63 Million CNY | 23.1% |
| 2009 Q1 | 321.38 Million CNY | 0.0% |
| 2008 Q4 | 321.38 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 773.65 Million HKD | -1596.934% |
| Lee & Man Chemical Company Limited | 4.05 Billion HKD | -224.112% |